CVM.AMEXCel Sci CORP

Form 4: CEL-SCI Corp: Chief Scientific Officer Talor Eyal Reports Acquisition of Shares

Sentiment:

SEC Form 4 Filing


Chief Scientific Officer Talor Eyal reports acquiring 10,416 shares of CEL-SCI Corp at $0.2304 per share on March 31, 2025.

Summary

  • On March 31, 2025, Eyal Talor, the Chief Scientific Officer of CEL-SCI Corp, acquired 10,416 shares of common stock.
  • The shares were purchased at a price of $0.2304 per share.
  • Following the transaction, Talor Eyal directly owns 135,013 shares of CEL-SCI Corp.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing an insider transaction, which is neutral in sentiment.

Industry Context

This Form 4 filing is a routine disclosure of insider trading activity, providing transparency to the market regarding the transactions of company executives.

Stakeholder Impact

  • The transaction provides information to shareholders regarding insider confidence (or lack thereof) in the company's prospects.

Key Dates

DateDescription
03/31/2025Date of transaction: Eyal Talor acquired shares of CEL-SCI Corp.
04/01/2025Date of signature on the report.

Keywords

Form 4, Beneficial Ownership, CEL-SCI Corp, CVM, Talor Eyal, Chief Scientific Officer, Share Acquisition, Insider Transaction

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.